Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02898259
Brief Title: Lenalidomide, Ixazomib, and Rituximab as Front-Line Therapy for High Risk Indolent B-Cell Lymphoma

First Submitted : September 8, 2016
First Submitted that Met QC Criteria : September 8, 2016
First Posted : September 13, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : November 12, 2019
Last Update Posted : November 13, 2019